Literature DB >> 14063078

BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.

B J FREEDMAN.   

Abstract

Entities:  

Keywords:  AEROSOLS; BRONCHITIS; ISOPROTERENOL; PREDNISOLONE; PULMONARY EMPHYSEMA; RESPIRATORY INSUFFICIENCY; SPIROMETRY

Mesh：

Substances：

Year:  1963        PMID： 14063078      PMCID： PMC1873709          DOI： 10.1136/bmj.2.5371.1509

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  14 in total

1.  Use of corticotrophin gel and cortisone in treatment of severe and intractable asthma.

Authors:  B M DAVIES; D A WILLIAMS
Journal:  Br Med J       Date:  1955-07-30

2.  Steroid therapy in chronic bronchitis.

Authors:  M CLIFTON; C H STUART-HARRIS
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

3.  Long-continued treatment with tetracycline and prednisolone in chronic bronchitis; a controlled trial.

Authors:  E N MOYES; R A KERSHAW
Journal:  Lancet       Date:  1957-12-14       Impact factor: 79.321

4.  Corticotrophin in treatment of acute exacerbations of chronic bronchitis.

Authors:  D FELIX-DAVIES; E K WESTLAKE
Journal:  Br Med J       Date:  1956-04-07

5.  Cortisone and corticotrophin in asthma.

Authors:  H NICHOLSON
Journal:  Practitioner       Date:  1955-11

6.  Normal standards for lung volumes, intrapulmonary gas-mixing, and maximum breathing capacity.

Authors:  C D NEEDHAM; M C ROGAN; I McDONALD
Journal:  Thorax       Date:  1954-12       Impact factor: 9.139

7.  A practical measure of the maximum ventilatory capacity in health and disease.

Authors:  M C S KENNEDY
Journal:  Thorax       Date:  1953-03       Impact factor: 9.139

8.  The effect of the rate of breathing on the maximum breathing capacity determined with a new spirometer.

Authors:  L BERNSTEIN; J L D'SILVA; D MENDEL
Journal:  Thorax       Date:  1952-09       Impact factor: 9.139

9.  Analysis of the ventilatory defect by timed capacity measurements.

Authors:  E A GAENSLER
Journal:  Am Rev Tuberc       Date:  1951-09

10.  The use of prednisone (Meticorten) in respiratory disease. II. Pulmonary emphysema and pulmonary fibrosis.

Authors:  H A BICKERMAN; G J BECK; A L BARACH
Journal:  J Chronic Dis       Date:  1955-09
View more
  9 in total

1.  Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.

Authors:  C R Swinburn; J M Wakefield; S P Newman; P W Jones
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

2.  A controlled trial of prednisone, in low dosage, in patients with chronic airways obstruction.

Authors:  J A Evans; I M Morrison; K B Saunders
Journal:  Thorax       Date:  1974-07       Impact factor: 9.139

3.  A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma.

Authors:  G K Crompton
Journal:  Thorax       Date:  1968-01       Impact factor: 9.139

4.  Steroids in bronchitis.

Authors: 
Journal:  Br Med J       Date:  1980-10-25

5.  A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.

Authors:  S M Harding; S Freedman
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

6.  Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.

Authors:  P G Curzon; M A Martin; N J Cooke; M F Muers
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

7.  Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction.

Authors:  A L James; K E Finucane; G Ryan; A W Musk
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

8.  Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.

Authors:  D M Mitchell; P Gildeh; M Rehahn; A Dimond; J V Collins
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

9.  Evaluation of a novel method to assess corticosteroid responsiveness in chronic obstructive pulmonary disease.

Authors:  Fahad A Al-Ghimlas; Andrew McIvor
Journal:  Ann Thorac Med       Date:  2010-10       Impact factor: 2.219
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.